期刊文献+

股骨粗隆间骨折骨代谢生化指标测定 被引量:12

Determination of biochemical markers of bone metabolism in elderly patients with femoral intertrochanteric fracture
原文传递
导出
摘要 目的测定股骨粗隆间骨折患者的血骨代谢生化指标以期预测骨折发生的危险性。方法对142例60岁以上老年股骨粗隆间骨折(骨折组)和141例老年骨质疏松但非骨折患者(对照组)进行血骨代谢测定,测定指标包括Ⅰ型前胶原氨基端延长肽(P1NP)、Ⅰ型胶原羧基端β特殊序列(β-CTX)、骨钙素(OC)、甲状旁腺素(PTH)、25(OH)D3。结果骨折组P1NP、β-CTX、OC和PTH高于对照组,组间差异有统计学意义(P<0.05);两组25(OH)D3差异无统计学意义(P>0.05)。结论老年骨质疏松患者血骨代谢测定中P1NP、PTH、β-CTX和OC增高,可能预测股骨粗隆间骨折风险增高,由此可以识别股骨粗隆间骨折高风险人群并给予及时的抗骨质疏松治疗。 Objective To measure the biochemical markers of bone metabolism in the elderly patients with femoral intertrochanteric fracture in order to evaluate the risks of fragile hip fracture. Methods The mean serum levels of procollagen type 1 aminoterminal propeptide (P1NP), cross-linked C-terminal telopeptide of type I collagen (β-CTX),osteocalcin(OC), parathyroid hormone(PTH) and 25 (OH)D3 were measured in 142 patients, over 60 years old with femoral intertrochanteric fracture and 141 elderly patients without fracture history. Results The mean serum levels of P1NP, β-CTX,OC and FrH in fracture group were significantly higher than that in the control greup(P 〈0.05), no difference was found regarding 25(OH)D3 (P 〉0.05). Conclusion Serum P1NP, β-CTX, OC and PTH levels in osteoporetic patients were positively correlated with fragile hip fracture risk, and it is helpful to give those individuals appropriate osteoporosis treatment in time.
出处 《中国骨与关节损伤杂志》 2013年第12期1140-1142,共3页 Chinese Journal of Bone and Joint Injury
基金 上海市卫生局课题(2009037)
关键词 股骨粗隆间骨折 骨代谢指标 骨质疏松 Femoral intertrochanteric fracture Biochemical markers Osteoporosis
  • 相关文献

参考文献13

  • 1郭永智,王晓伟,刘智,周猛,孙天胜.老年骨质疏松性髋部骨折风险预测[J].中国骨与关节损伤杂志,2012,27(10):879-881. 被引量:13
  • 2Hanon RA,Enstell R. Biochemical markers of bone turnover and fracture prediction[J].J Br Menopause Soc,2003,(01):10-15.
  • 3ShigaT,Tsuji Y,Fujoka M. Risk factors for hip fracture in Japanese elderly women with osteoporosis applicability of biochemical markers in bone turnover[J].Geriatr Genotol Int,2009,(01):69-74.
  • 4Zhao J,Xia W,Nie M,ctal. The levels of bone turnover markers in Chinese postmenopausal women:Peking vertebral fracture study[J].{H}MENOPAUSE-THE Journal OF THE NORTH AMERICAN MENOPAUSE SOCIETY,2011,(11):1237-1243.
  • 5严海燕,曾华,罗玲,罗晓红,陈梅,丁鹤林.三种骨代谢标志物在诊断及鉴别骨疾病中的应用[J].中国骨与关节损伤杂志,2012,27(9):859-860. 被引量:6
  • 6Bauer DC,Garnero P,Harrison SL. Biochemical markers of bone turnover,hip bone loss,and fracture in older men:the MrOS study[J].{H}Journal of Bone and Mineral Research,2009,(12):2032-2038.
  • 7Aonuma H,Miyakoshi N,Hongo M. Low serum levels of undercarboxylated osteocalcin in postmenopausal osteoporotic women receiving an inhibitor of bone response[J].Tohuko J Exp Med,2009,(03):201-205.
  • 8Plantalech L,Guillaumont M,Vergnaud P. Impairment of gamma carboxylation of circulating osteocalcin (bone gla protein) in elderly women[J].{H}Journal of Bone and Mineral Research,1999,(11):1211-1216.
  • 9Szulc P,Chapuy MC,Meunier PJ. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture:a three year followup study[J].{H}BONE,1996,(05):487-488.
  • 10Emaus N,Nguyan ND,Almns B. Serum level of undercarboxylated osteocalcin an bone mineral density in early menopausal Norweigian women[J].{H}EUROPEAN JOURNAL OF NUTRITION,2013,(01):49-55.

二级参考文献17

  • 1PoUmann D,Siepmann S,Geppert R,et al. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer[J].Antieancer Res,2007,27(4) : 1853-1862.
  • 2Pronchenko IA,Buzulina VP,Tomolina NA, et al.Biochemical markers of bone metabolism and bone tissue losses after allotransplantation of the cadaveric kidney: a cross-sectional [J].Klin Lab Diagn, 2005,11:3-8.
  • 3Koizumi M.The semm level of the amino-terminal propeptide of type I proconagen is a sensitive marker for prostate cancer metastasis to bone[J].BJU Int,2001,87(4):3482-3511.
  • 4Cornwall R ,Gilbert MS,Koval KJ,et al. Functional outcomes and mortality vary among different types of hip fractures: a function of patient characteristics[J]. Clin Orthop Relat Res,2004,425: 64-71.
  • 5Kanis JA,Oden A,Johnell O,ct al. The components of excess mor- tality after hip fracture[J]. Bone,2003,32(5):468-473.
  • 6Sharma H, Vashishtha P, Sharma R, et al. Gender differences in pa- tients with hip fracture: a greater risk of morbidity and mortality in men[J]. Orthop Trauma,2005,19: 365-366.
  • 7Nakamura K,Takahashi S,Oyama M ,et al. Prior non-;hip limb frac- ture predicts subsequent hip fracture in institutionalized elderly peo- ple[J]. Osteoporos Int,2010,21(8):1411-1416.
  • 8Netfleman M,Aisip J,Schrader M,et al. Predictors of mortality after acute hip fracture[J]. J Gen Intern Med, 1996,11: 765-767.
  • 9Jorgensen NR,Schwarz P,Holme I, et al. The prevalence of osteo- porosis in patients with chronic obstructive pulmonary disease: a cross sectional study[J]. Respiratory Medlcine,2007,101: 177-185.
  • 10Hoidrup S,Preseott E,Soresen TI,et al. Tobacco smoking and risk of hip fracture in men and women [J]. Int J Epi Emiology,2000,29: 253 -259.

共引文献17

同被引文献171

引证文献12

二级引证文献149

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部